Drug recall · April 19, 2017
hydrALAZINE HYDROCHLORIDE INJECTION recall
Why: Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL 60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.
- Lots / codes
Lot #s: 6114311, 6114717, Exp 05/18
- Quantity
- 98 vials
- Company
- Mckesson Medical Surgical, Henrico, VA
- Distribution
- Nationwide in the USA
- Initiated
- March 8, 2017 · Voluntary: Firm initiated
- Classified
- April 12, 2017
- Reported
- April 19, 2017
- Ended
- August 19, 2024
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydralazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.